High-Throughput Mechanistic Screening of Epigenetic Compounds for the Potential Treatment of Meningiomas

Background: Meningiomas are the most common primary central nervous system tumors. 20–30% of these tumors are considered high-grade and associated with poor prognosis and high recurrence rates. Despite the high occurrence of meningiomas, there are no FDA-approved compounds for the treatment of these...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Tatman, Philip D., Wroblewski, Tadeusz H., Fringuello, Anthony R., Scherer, Samuel R., Foreman, William B., Damek, Denise M., Lillehei, Kevin, Youssef, A. Samy, Jensen, Randy L., Graner, Michael W., Ormond, D. Ryan
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8303324/
https://ncbi.nlm.nih.gov/pubmed/34300316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10143150
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi